DEUTSCHE BANK AG\ - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$101,400,000
+485.3%
4,363,330
+300.9%
0.03%
+250.0%
Q1 2018$17,323,000
-71.0%
1,088,470
-62.1%
0.01%
-78.9%
Q4 2017$59,660,000
+34.6%
2,871,121
-7.1%
0.04%
+26.7%
Q3 2017$44,308,000
+77.2%
3,092,190
+114.0%
0.03%
+66.7%
Q2 2017$25,000,000
+406.3%
1,445,248
+222.7%
0.02%
+350.0%
Q1 2017$4,938,000
-44.5%
447,910
-27.0%
0.00%
-42.9%
Q4 2016$8,905,000
-30.5%
613,513
+17.6%
0.01%
-22.2%
Q3 2016$12,806,000
+227.1%
521,742
+168.3%
0.01%
+200.0%
Q2 2016$3,915,000
-85.2%
194,448
-80.7%
0.00%
-85.0%
Q1 2016$26,480,000
-89.5%
1,006,962
-59.3%
0.02%
-88.5%
Q4 2015$251,420,000
+330.3%
2,473,425
+655.1%
0.17%
+286.7%
Q3 2015$58,425,000
-19.2%
327,560
+0.6%
0.04%
-2.2%
Q2 2015$72,319,000
+7.2%
325,558
-4.2%
0.05%
+9.5%
Q1 2015$67,477,000
-54.5%
339,758
-67.2%
0.04%
-53.8%
Q4 2014$148,301,000
-20.5%
1,036,308
-27.1%
0.09%
-21.6%
Q3 2014$186,511,000
+425.9%
1,421,614
+405.5%
0.12%
+383.3%
Q2 2014$35,463,000
+73.5%
281,208
+80.6%
0.02%
+60.0%
Q1 2014$20,443,000
-16.6%
155,688
-25.9%
0.02%
-16.7%
Q4 2013$24,514,000
+84.2%
210,096
+62.6%
0.02%
+80.0%
Q3 2013$13,310,000129,1720.01%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2018
NameSharesValueWeighting ↓
Brave Warrior Advisors 5,701,010$1,266,479,00036.57%
Ruane, Cunniff & Goldfarb 33,884,050$7,527,342,00035.90%
LeVasseur Capital Partners LLC 188,804$41,943,00034.97%
Pershing Square Capital Management 19,473,933$4,326,134,00029.95%
FARLEY CAPITAL L.P. 141,020$31,328,00024.16%
Ratan Capital Management LP 1,038,033$230,599,00021.97%
Marble Arch Investments 1,069,000$237,478,00020.47%
Arrow Capital Management, LLC 144,461$32,092,00018.04%
Tesuji Partners 1,368,040$303,910,00017.93%
ValueAct Holdings 14,994,261$3,330,975,00017.54%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders